BriaCell Therapeutics Corp. (BCTX) stock: key figures, P/E, revenue and dividend
Health Care · Canada · ISIN CA10778Y3023
BriaCell Therapeutics Corp. financials
| Fiscal year | 2025 | 2026 |
|---|---|---|
| Operating income | -27.20 m USD | -36.05 m USD |
| EBIT | -26.64 m USD | -35.93 m USD |
| Net income | -26.31 m USD | -34.90 m USD |
| Diluted EPS – continuing operations | -62.19 USD | -6.97 USD |
Full history since 2006, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp., has a collaboration with MSK Accelerator to accelerate the clinical development of Bria-OTS+ for multiple cancer indications including metastatic breast cancer, prostate cancer, and other cancers. The company is headquartered in West Vancouver, Canada.
More stocks
- Cell Source, Inc. (CLCS)
- JONES SODA CO. (JSDA)
- SEAFARER EXPLORATION CORP (SFRX)
- RAVE RESTAURANT GROUP, INC. (RAVE)
- Paradium AI, Inc. (PAAI)
- HARTE HANKS INC (HHS)
- ProMIS Neurosciences Inc. (PMN)
- RYTHM, Inc. (RYM)
- Quest Resource Holding Corp (QRHC)
- Kestrel Group Ltd (KG)
- Grandstand Limited (GRSD)
- NextCure, Inc. (NXTC)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.